Somatostatin Receptor Type 2 Antagonism (SSTR2a) Augments Glucagon Counterregulation and Delays Hypoglycemia Onset in Type 2 Diabetic (T2D), Sprague-Dawley Rats

被引：0
|
作者：
Hoffman, Emily G.
Dsouza, Ninoschka
Aiken, Julian
Liggins, Richard
Riddell, Michael
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-133-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
133-OR
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Effects of Sustained Somatostatin Receptor 2 Antagonism (SSTR2a) on Glycemia in Type 2 Diabetic (T2D) Male Rats-A Pilot Study
    Aleali, Nadia
    D'Souza, Ninoschka C.
    Shakeri, Dorsa
    Simonson, Eric
    Liggins, Richard
    Chan, Owen
    Riddell, Michael C.
    DIABETES, 2023, 72
  • [2] Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counterregulation in Biobreeding Diabetic Rats
    Karimian, Negar
    Qin, Tairan
    Liang, Tao
    Osundiji, Mayowa
    Huang, Yachi
    Teich, Trevor
    Riddell, Michael C.
    Cattral, Mark S.
    Coy, David H.
    Vranic, Mladen
    Gaisano, Herbert Y.
    DIABETES, 2013, 62 (08) : 2968 - 2977
  • [3] Effect of Somatostatin Receptor 2 Antagonist (SSTR2a) on Glycemia and Glucagon Levels in a Rat Model of Type 2 Diabetes (T2D)
    D'Souza, Ninoschka C.
    Hoffman, Emily G.
    Atherley, Sara C.
    Champsi, Sabrina
    Popkov, Mariya
    Liggins, Richard
    Riddell, Michael
    DIABETES, 2021, 70
  • [4] Effect of Somatostatin Receptor 2 Antagonism (SSTR2a) on Oral Glucose Tolerance (OGT) in a Rat Model of Type 2 Diabetes (T2D)
    D'Souza, Ninoschka C.
    Aleali, Nadia
    Shakeri, Dorsa
    Hoffman, Emily G.
    Atherley, Sara C.
    Champsi, Sabrina
    El-Zahed, Maya
    Liggins, Richard
    Chan, Owen
    Riddell, Michael C.
    DIABETES, 2023, 72
  • [5] Somatostatin type 2 receptor antagonism improves glucagon and corticosterone counterregulation to hypoglycaemia in STZ-diabetic rats
    Yue, J. T. Y.
    Burdett, E.
    Coy, D. H.
    Efendic, S.
    Vranic, M.
    DIABETOLOGIA, 2009, 52 : S236 - S237
  • [6] The Glucagon Stimulating Effect in Hypoglycemia of Somatostatin Receptor 2 Antagonist (SSTR2a) Is Maintained with Repeat Dosing
    Dsouza, Ninoschka
    Aleali, Nadia
    Shakeri, Dorsa
    Atherley, Sara C.
    Hoffman, Emily G.
    Karimi-Chahartash, Sina
    Javanbakhsh, Sahel
    Chan, Owen
    Liggins, Richard
    Riddell, Michael C.
    DIABETES, 2024, 73
  • [7] Normalization of the Glucagon Response to Hypoglycemia in STZ-Diabetic Rats Via Somatostatin Type 2 Receptor Antagonism
    Yue, Jessica T. Y.
    Burdett, Elena
    Coy, David H.
    Efendic, Suad
    Vranic, Mladen
    DIABETES, 2009, 58 : A35 - A35
  • [8] Impact of SSTR2a Treatment in Hypoglycemia in Male (M) and Female (F) Rat Models of Type 2 Diabetes (T2D)
    Dsouza, Ninoschka
    Aleali, Nadia
    Shakeri, Dorsa
    Atherley, Sara C.
    Hoffman, Emily G.
    Karimi-Chahartash, Sina
    Javanbakhsh, Sahel
    Chan, Owen
    Liggins, Richard
    Riddell, Michael C.
    DIABETES, 2024, 73
  • [9] Amelioration of Hypoglycemia Via Somatostatin Receptor Type 2 Antagonism in Recurrently Hypoglycemic Diabetic Rats
    Yue, Jessica T. Y.
    Burdett, Elena
    Coy, David H.
    Efendic, Suad
    Vranic, Mladen
    DIABETES, 2010, 59 : A205 - A206
  • [10] Amelioration of Hypoglycemia Via Somatostatin Receptor Type 2 Antagonism in Recurrently Hypoglycemic Diabetic Rats
    Yue, Jessica T. Y.
    Riddell, Michael C.
    Burdett, Elena
    Coy, David H.
    Efendic, Suad
    Vranic, Mladen
    DIABETES, 2013, 62 (07) : 2215 - 2222
12345